AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

RegeneRx Biopharmaceuticals, Inc.

$0 +$0.00 (+266.67%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0.16
Year Range
$0$0.16
Market Cap
1.65K
AVG Volume
13
Trailing/Forward PE
-0/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
05K10K15K20K20 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
RGRX Revenue (USD) by quarter
PeriodRevenue (USD)
23 Q119.19K
22 Q419.19K
22 Q319.19K
22 Q219.19K
22 Q119.19K
21 Q419.19K
21 Q319.19K
21 Q219.19K
21 Q119.19K
20 Q419.19K
Net Income (USD)
-600K-400K-200K020 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
RGRX Net Income (USD) by quarter
PeriodNet Income (USD)
23 Q1-385K
22 Q4-391K
22 Q3-366K
22 Q2-546K
22 Q1-424K
21 Q4-450K
21 Q3-430K
21 Q2-339K
21 Q1-380K
20 Q4-367.88K
Operating Income (USD)
-600K-400K-200K020 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
RGRX Operating Income (USD) by quarter
PeriodOperating Income (USD)
23 Q1-305K
22 Q4-309K
22 Q3-284K
22 Q2-465K
22 Q1-344K
21 Q4-368K
21 Q3-404K
21 Q2-257K
21 Q1-299K
20 Q4-290.71K
EBITDA (USD)
-400K-300K-200K-100K0100K20 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
RGRX EBITDA (USD) by quarter
PeriodEBITDA (USD)
23 Q1-304.99K
22 Q4-155
22 Q3463
22 Q2-158
22 Q1-159
21 Q4-398
21 Q355.05K
21 Q2447
21 Q1416
20 Q4-290.31K
Cash Flows (USD)
-600K-400K-200K020 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
RGRX Cash Flows (USD) by quarter
PeriodCash Flows (USD)
23 Q1-189.33K
22 Q4-187.52K
22 Q3-228.24K
22 Q2-218.66K
22 Q1-306.3K
21 Q4-291.78K
21 Q3-430.64K
21 Q2-25.54K
21 Q1-242.33K
20 Q4-208.51K
EPS (USD)
-0-0-0-0020 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
RGRX EPS (USD) by quarter
PeriodEPS (USD)
23 Q1-0
22 Q4-0
22 Q3-0
22 Q2-0
22 Q1-0
21 Q4-0
21 Q3-0
21 Q2-0
21 Q1-0
20 Q4-0
Expenses (USD)
-200K0200K400K600KR&DSG&ACapex20 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
RGRX Expenses (USD) by quarter
PeriodExpenses (USD)
23 Q1324.1K
22 Q4328.04K
22 Q3303.65K
22 Q2484.03K
22 Q1363.03K
21 Q4387.77K
21 Q3423.24K
21 Q2276.64K
21 Q1318.61K
20 Q4309.9K
Cash & Debt (USD)
01M2M3MCashLong Term DebtShort Term Debt20 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
RGRX Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
23 Q1101.56K
22 Q4290.89K
22 Q3478.41K
22 Q2706.65K
22 Q1925.3K
21 Q41.23M
21 Q31.52M
21 Q22.03M
21 Q1207.61K
20 Q4427.9K
Debt ratios
-150000-100000-5000005000020 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
RGRX Debt ratios by quarter
PeriodDebt ratios
23 Q1-4.57
22 Q4-128381
22 Q3-3612.08
22 Q210.15
22 Q15.21
21 Q4-1.2
21 Q31.74
21 Q21.58
21 Q1-0.91
20 Q4-0.46
Margins
0%25%50%75%100%20 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
RGRX Margins by quarter
PeriodMargins
23 Q1100%
22 Q4100%
22 Q3100%
22 Q2100%
22 Q1100%
21 Q499.99%
21 Q399.97%
21 Q299.99%
21 Q199.99%
20 Q499.99%
Return on Capital
0%10%20%30%20 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
RGRX Return on Capital by quarter
PeriodReturn on Capital
23 Q110.28%
22 Q411.35%
22 Q311.65%
22 Q219.09%
22 Q116.52%
21 Q420.18%
21 Q323.01%
21 Q221.83%
21 Q112.18%
20 Q413.03%
Shares Outstanding
050M100M150M20 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
RGRX Shares Outstanding by quarter
PeriodShares Outstanding
23 Q1143.5M
22 Q4143.55M
22 Q3143.55M
22 Q2143.55M
22 Q1143.55M
21 Q4143.48M
21 Q3143.48M
21 Q2133.66M
21 Q1133.52M
20 Q4133.44M
Book Value Per Share (USD)
-0.03-0.02-0.01020 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
RGRX Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
23 Q1-0.03
22 Q4-0.02
22 Q3-0.02
22 Q2-0.02
22 Q1-0.02
21 Q4-0.02
21 Q3-0.01
21 Q2-0.01
21 Q1-0.02
20 Q4-0.02
Total Assets (USD)
01M2M3M20 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
RGRX Total Assets (USD) by quarter
PeriodTotal Assets (USD)
23 Q1186.81K
22 Q4382.18K
22 Q3580.99K
22 Q2735.5K
22 Q1960.53K
21 Q41.28M
21 Q31.59M
21 Q22.11M
21 Q1315.44K
20 Q4551.79K
Employee Count
02462013201420152016201720182019202020212022
RGRX Employee Count by quarter
PeriodEmployee Count
20222
20213
20203
20193
20183
20173
20163
20153
20142
20135
PE Ratio
050001000015000med 2156.37Apr 17Jun 17Jul 17Aug 17Oct 17Mar 18May 18
RGRX PE Ratio by quarter
PeriodPE Ratio
May 187626.18
May 187626.18
Apr 188388.8
Apr 187626.18
Apr 188045.62
Apr 188270.6
Mar 188388.8
Nov 171845.29
Nov 172050.32
Oct 172544.51
Oct 172333.12
Oct 172333.12
Oct 172262.42
Sep 172333.12
Sep 172403.82
Sep 172036.18
Sep 172049.61
Sep 171979.62
Aug 171873.57
Aug 17789.99
Aug 17798.61
Aug 17868.7
Jul 17804.35
Jul 17757.82
Jul 17740.87
Jul 17753.79
Jun 17775.63
Jun 17775.63
Jun 17746.9
Jun 17804.35
Jun 17804.35
May 17817.28
May 17804.35
May 1712964.85
May 1713757.67
Apr 1713398.57
Apr 1713519.82
Apr 1713990.85
Apr 1713990.85
Mar 1713524.48
Free Cash Flow Yield
-3000%-2000%-1000%0%med -1148.08%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
RGRX Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-521.85%
Sep 26-521.85%
Aug 26-820.06%
Aug 26-820.06%
Aug 26-820.06%
Aug 26-820.06%
Jul 26-956.73%
Jul 26-956.73%
Jul 26-956.73%
Jul 26-956.73%
Jul 26-956.73%
Jun 26-956.73%
Jun 26-956.73%
Jun 26-956.73%
Jun 26-956.73%
May 26-956.73%
May 26-1148.08%
May 26-1148.08%
May 26-1148.08%
May 26-1148.08%
Apr 26-1148.08%
Apr 26-1148.08%
Apr 26-1913.47%
Apr 26-1913.47%
Mar 26-1913.47%
Mar 26-1913.47%
Mar 26-1913.47%
Mar 26-1913.47%
Feb 26-1913.47%
Feb 26-1913.47%
Feb 26-1913.47%
Feb 26-1913.47%
Jan 26-1913.47%
Jan 26-1913.47%
Jan 26-1913.47%
Jan 26-1913.47%
Jan 26-1913.47%
Dec 25-1913.47%
Dec 25-1913.47%
Dec 25-1913.47%
Dec 25-1913.47%
Nov 25-2870.2%
Nov 25-2870.2%
Nov 25-2870.2%
Nov 25-2870.2%
Oct 25-2870.2%
Oct 25-2870.2%
Oct 25-3.57%
Oct 25-3.57%
Oct 25-3.57%
Sep 25-2870.2%
Sep 25-2870.2%
Sep 25-2870.2%
Sep 25-2870.2%
Aug 25-2870.2%
Aug 25-2870.2%
Aug 25-2870.2%
Aug 25-2870.2%
Aug 25-114.81%
Jul 25-2870.2%
Jul 25-2870.2%
Jul 25-2870.2%
Jul 25-2870.2%
Jun 25-2870.2%
Jun 25-2870.2%
Jun 25-2870.2%
Jun 25-2870.2%
May 25-2870.2%
May 25-2870.2%
May 25-2870.2%
May 25-2870.2%
May 25-2870.2%
Apr 25-2870.2%
Apr 25-2870.2%
Apr 25-2870.2%
Apr 25-410.03%
Mar 25-410.03%
Mar 25-410.03%
Mar 25-410.03%
Mar 25-410.03%
Feb 25-410.03%
Feb 25-410.03%
Feb 25-410.03%
Feb 25-410.03%
Jan 25-410.03%
Jan 25-410.03%
Jan 25-410.03%
Jan 25-410.03%
Jan 25-410.03%
Dec 24-410.03%
Dec 24-7.83%
Dec 24-410.03%
Dec 24-410.03%
Nov 24-410.03%
Nov 24-410.03%
Nov 24-410.03%
Nov 24-410.03%
Nov 24-410.03%
Oct 24-410.03%
Oct 24-410.03%
Price to Sales
0100200300400med 0.93Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
RGRX Price to Sales by quarter
PeriodPrice to Sales
Sep 262.06
Sep 262.06
Aug 261.31
Aug 261.31
Aug 261.31
Aug 261.31
Jul 261.12
Jul 261.12
Jul 261.12
Jul 261.12
Jul 261.12
Jun 261.12
Jun 261.12
Jun 261.12
Jun 261.12
May 261.12
May 260.93
May 260.93
May 260.93
May 260.93
Apr 260.93
Apr 260.93
Apr 260.56
Apr 260.56
Mar 260.56
Mar 260.56
Mar 260.56
Mar 260.56
Feb 260.56
Feb 260.56
Feb 260.56
Feb 260.56
Jan 260.56
Jan 260.56
Jan 260.56
Jan 260.56
Jan 260.56
Dec 250.56
Dec 250.56
Dec 250.56
Dec 250.56
Nov 250.37
Nov 250.37
Nov 250.37
Nov 250.37
Oct 250.37
Oct 250.37
Oct 25300.98
Oct 25300.98
Oct 25300.98
Sep 250.37
Sep 250.37
Sep 250.37
Sep 250.37
Aug 250.37
Aug 250.37
Aug 250.37
Aug 250.37
Aug 259.35
Jul 250.37
Jul 250.37
Jul 250.37
Jul 250.37
Jun 250.37
Jun 250.37
Jun 250.37
Jun 250.37
May 250.37
May 250.37
May 250.37
May 250.37
May 250.37
Apr 250.37
Apr 250.37
Apr 250.37
Apr 252.62
Mar 252.62
Mar 252.62
Mar 252.62
Mar 252.62
Feb 252.62
Feb 252.62
Feb 252.62
Feb 252.62
Jan 252.62
Jan 252.62
Jan 252.62
Jan 252.62
Jan 252.62
Dec 242.62
Dec 24137.03
Dec 242.62
Dec 242.62
Nov 242.62
Nov 242.62
Nov 242.62
Nov 242.62
Nov 242.62
Oct 242.62
Oct 242.62
EV/EBITDA
0200004000060000med 7632.86May 17Jul 17Oct 17May 18Jun 22Aug 22Nov 22
RGRX EV/EBITDA by quarter
PeriodEV/EBITDA
Nov 2240646.23
Nov 2239642.22
Oct 2240408.44
Oct 2246538.2
Oct 2246987.36
Oct 2242284.36
Sep 2237000.08
Sep 2239642.22
Sep 2245243.55
Sep 2243341.21
Sep 2244926.5
Aug 2245058.6
Aug 2242284.36
Aug 2248361.28
Aug 2242284.21
Jul 2248346.46
Jul 2244426.9
Jul 2249574.59
Jul 2239200.82
Jul 2240507.34
Jun 2242231.95
Jun 2247039.94
Jun 2245210.81
Jun 2248346.46
May 2249652.98
May 2247144.46
May 2249109.37
May 2251668.29
Apr 2228431.24
Apr 2241355.07
Apr 2246188.58
Apr 2243293.65
Apr 2247377.58
May 183909.08
May 183909.08
Apr 184299.9
Apr 183909.08
Apr 184124.03
Apr 184239.32
Mar 184299.9
Nov 171653.12
Nov 171836.75
Oct 172279.39
Oct 172090.05
Oct 172090.05
Oct 172026.72
Sep 172090.05
Sep 172153.37
Sep 171824.09
Sep 171836.12
Sep 171773.43
Aug 171678.45
Aug 17754.34
Aug 17762.57
Aug 17829.49
Jul 17768.05
Jul 17723.62
Jul 17707.44
Jul 17719.78
Jun 17740.63
Jun 17740.63
Jun 17713.2
Jun 17768.05
Jun 17768.05
May 17780.4
May 17768.05
May 177317.02
May 177764.46
Apr 177561.8
Apr 177630.23
Apr 177896.06
Apr 177896.06
Mar 177632.86
RegeneRx Biopharmaceuticals, Inc.
RGRX
Stockpicker

Video analysis: RGRX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.